ASRT can do this?
"Assertio is a pharmaceutical company that sells prescription products in 3 areas: neurology, hospital, and pain and inflammation. The company is currently undergoing major restructuring and has recently merged with Zyla Life Sciences. They have 7 FDA approved products in the marketplace.
Assertio currently has a market cap of only $150 million and has raised $50 million in direct offerings over the past week. ASRT has been on a bullish run with the price is currently up 45% in 1 week and it closed at $1.09 yesterday. This is despite 2 offerings that have been announced. The price skyrocketed off the closure of the first offering priced at $0.62 and I believe it will do the same with the current offering. Prior to the announcement of the recent offering (@$0.98), the price hit $1.45 on Tuesday. Given that the offering will not result in dilution, I believe any price under $1.1 is a good buy point"
Quoting - u/TruePriest
My target is 3$ depending on the earnings report next month. My RR ratio is 1:4
While we speak let's just avg down or up.
(Disclaimer)
(This is not financial advice, just my opinion)
Assertio currently has a market cap of only $150 million and has raised $50 million in direct offerings over the past week. ASRT has been on a bullish run with the price is currently up 45% in 1 week and it closed at $1.09 yesterday. This is despite 2 offerings that have been announced. The price skyrocketed off the closure of the first offering priced at $0.62 and I believe it will do the same with the current offering. Prior to the announcement of the recent offering (@$0.98), the price hit $1.45 on Tuesday. Given that the offering will not result in dilution, I believe any price under $1.1 is a good buy point"
Quoting - u/TruePriest
My target is 3$ depending on the earnings report next month. My RR ratio is 1:4
While we speak let's just avg down or up.
(Disclaimer)
(This is not financial advice, just my opinion)
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.